Metzger, Kristine, Frémont, Marc, Roelant, Chris et al. · Biochemical and biophysical research communications · 2008 · DOI
This study looked at a genetic variation in a protein called IL-17F that affects immune system inflammation. Researchers found that ME/CFS patients were less likely to carry a protective version of this genetic variant compared to healthy people. This suggests that the immune system's inflammatory response, particularly from a type of immune cell called Th17 cells, may play a role in ME/CFS.
ME/CFS is characterized by persistent immune activation and abnormal cytokine profiles, but the underlying mechanisms remain unclear. This study identifies a specific genetic factor that may predispose individuals to develop the disease, providing potential insight into the immune dysregulation seen in ME/CFS and suggesting therapeutic targets related to Th17 cell function.
This study does not prove that the IL-17F variant causes ME/CFS, only that it is associated with the disease. Genetic association does not establish causation, and the finding requires replication in larger, diverse populations. This single-gene study does not explain the complex, multifactorial nature of ME/CFS pathogenesis.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.